About NGB Diagnostics
NGB Diagnostics is a company based in Delhi (India) by Rakesh Maurya. It operates as a B2B. NGB Diagnostics offers products and services including Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Protein Identification, and iTRAQ Protein Quantification. NGB Diagnostics operates in a competitive market with competitors including Abcam, Arbor Biotechnologies, Singleron, Stem Cell Technologies and Octant, among others.
- Headquarter Delhi, India
- Founders Rakesh Maurya
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ngb Diagnostics Private Limited
- Date of Incorporation 05 Jun, 2012
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$407.68 K (USD)-31.69as on Mar 31, 2023
-
Net Profit
$6.06 K (USD)-36.19as on Mar 31, 2023
-
EBITDA
$9.02 K (USD)-35.19as on Mar 31, 2023
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NGB Diagnostics
NGB Diagnostics offers a comprehensive portfolio of products and services, including Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Protein Identification, and iTRAQ Protein Quantification. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for sequencing entire genomes for research.
Sequencing of exomes for targeted genetic analysis.
Analysis of RNA transcripts for gene expression studies.
Identification of proteins using advanced techniques.
Quantification method for proteomic profiling.
Funding Insights of NGB Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by NGB Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NGB Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ngb Diagnostics Comparisons
Competitors of NGB Diagnostics
NGB Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Arbor Biotechnologies, Singleron, Stem Cell Technologies and Octant, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Genomic technologies and drug discovery platforms are provided.
|
|
| domain | founded_year | HQ Location |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Human cell interaction platform is provided for drug discovery.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic device and kits
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about NGB Diagnostics
Where is NGB Diagnostics located?
NGB Diagnostics is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Who is the current CEO of NGB Diagnostics?
Rakesh Maurya is the current CEO of NGB Diagnostics. They have also founded this company.
What is the annual revenue of NGB Diagnostics?
Annual revenue of NGB Diagnostics is $407.68K as on Mar 31, 2023.
What does NGB Diagnostics do?
NGB Diagnostics Private Limited, founded in 2012, delivers high-quality genomics and proteomics services using advanced bioinformatic pipelines. They specialize in whole genome sequencing, RNA sequencing, and protein analysis for clinical diagnostics, pharmaceutical, RD, and agro-food sectors. Based in India, they focus on affordable solutions with certified laboratories and cater to clients in healthcare and biotechnology industries.
Who are the top competitors of NGB Diagnostics?
NGB Diagnostics's top competitors include Abcam, Arbor Biotechnologies and Meridian Bioscience.
What products or services does NGB Diagnostics offer?
NGB Diagnostics offers Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Protein Identification, and iTRAQ Protein Quantification.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.